Differences between integrin α5β1 and EGRF receptor in signal pathways controlling proliferation and apoptosis of MCF-7/Dox human breast carcinoma cells


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

In MCF-7/Dox human breast carcinoma cells, down-regulation of integrin α5β1 and inhibition of epidermal growth factor receptor (EGFR) markedly reduced cell proliferation. Cell cycle analysis showed that α5β1 down-regulation resulted in cycle arrest at the S-phase, followed by a significant increase in the population of apoptotic cells (subG1 population). Inhibition of EGFR activity also caused cell cycle arrest at the S-phase but without any increase in the subG1 population. Down-regulation of α5β1 and EGFR inhibition resulted in a significant decrease of cell content of the active (phosphorylated) forms of FAK and Erk protein kinases. The data obtained suggest that α5β1 integrin is implicated in cell growth control via inhibition of apoptotic cell death and through EGFR activation.

About the authors

N. I. Kozlova

Institute of Biomedical Chemistry

Email: 1938berman@gmail.com
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

G. E. Morozevich

Institute of Biomedical Chemistry

Email: 1938berman@gmail.com
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

N. A. Ushakova

Institute of Biomedical Chemistry

Email: 1938berman@gmail.com
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

N. M. Gevorkian

Institute of Biomedical Chemistry

Email: 1938berman@gmail.com
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

A. E. Berman

Institute of Biomedical Chemistry

Author for correspondence.
Email: 1938berman@gmail.com
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Pleiades Publishing, Ltd.